Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus

Journal of Clinical Investigation

Volumn 125, Issue 3, 2015, Pages 993-1005

  Byrska Bishop, Marta ^a   VanDorn, Daniel ^b   Campbell, Amy E ^b   Betensky, Marisol ^b   Arca, Philip R ^b   Yao, Yu ^c   Gadue, Paul ^b   Costa, Fernando F ^d   Nemiroff, Richard L ^e   Blobel, Gerd A ^b   French, Deborah L ^b   Hardison, Ross C ^a   Weiss, Mitchell J ^c   Chou, Stella T ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 1; CHROMATIN; GATA1 PROTEIN, HUMAN; TRANSCRIPTOME;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING; DOWN REGULATION; EMBRYONIC STEM CELL; ERYTHROID CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MEGAKARYOCYTE ERYTHROID PROGENITOR; MEGAKARYOPOIESIS; MOUSE; MYELOPOIESIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SINGLE CELL ANALYSIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHROMATIN; ERYTHROPOIESIS; GENETIC EPIGENESIS; METABOLISM; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CELLS, CULTURED; CHROMATIN; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; ERYTHROID CELLS; ERYTHROPOIESIS; GATA1 TRANSCRIPTION FACTOR; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MUTATION; PROTEIN STRUCTURE, TERTIARY; SINGLE-CELL ANALYSIS; TRANSCRIPTOME;

EID: 84924029426     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75714     Document Type: Article

References (73)

1. Calligaris R, Bottardi S, Cogoi S, Apezteguia I, Santoro C. Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci U S A. 1995;92(25):11598-11602.
2. Hollanda LM, et al. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat Genet. 2006;38(7):807-812.
3. Sankaran VG, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest. 2012;122(7):2439-2443.
4. Parrella S, et al. Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype. Pediatr Blood Cancer. 2014;61(7):1319-1321.
5. Wechsler J, et al. Acquired muta tions in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32(1):148-152.
6. Alford KA, et al. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood. 2011;118(8):2222-2238.
7. Martin DI, Orkin SH. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev. 1990;4(11):1886-1898.
8. Weiss MJ, Yu C, Orkin SH. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol. 1997;17( 3):1642-1651.
9. Shimizu R, Takahashi S, Ohneda K, Engel JD, Yamamoto M. In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 2001;20(18) :5250-5260.
10. Kuhl C, Atzberger A, Iborra F, Nieswandt B, Porcher C, Vyas P. GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol Cell Biol. 2005;25(19):8592-8606.
11. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcripti on factor GATA-1. Proc Natl Acad Sci U S A. 1996;93(22):12355-12358.
12. Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stageselective effect of somati cally mutated leukemogenic transcription factor GATA1. Nat Genet. 2005;37(6):613-619.
13. Birger Y,et al Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder Blood. 2013 122 6, 988-998.
14. Woo AJ, et al. Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation. J Clin Invest. 2013; 123(8):3292-3304.
15. Kennedy M, D'Souza SL, Lynch-Kattman M, Schwantz S, Keller G. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood . 2007;109(7):2679-2687.
16. Niwa A, et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One. 2011;6(7):e22261.
17. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cell s. 2009;27(3):543-549.
18. Chou ST, et al. Trisomy 21-Associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109(43):17573-17578.
19. Anguera MC, et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell. 2012;11(1):75-90.
20. Tchieu J, et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell. 2010;7(3):329-342.
21. Ananiev G, Williams EC, Li H, Chang Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One. 2011;6(9):e25255.
22. Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K. Erosion of dosage compensat ion impacts human iPSC disease modeling. Cell Stem Cell. 2012;10(5):595-609.
23. Liang G, Zhang Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell. 2013;13(2):149-159.
24. Mills JA, et al. Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines. Blood. 2013;122(12):2047-2051.
25. McDevitt MA, Shivdasani RA, Fujiwara Y, Yang H, Orkin SH. A " knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A. 1997;94(13):6781-6785.
26. Pan X, et al. Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors. J Biol Chem. 2005;280(23):22385-22394.
27. Encode Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
28. M ootha VK, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267-273.
29. Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.
30. Novershtern N, et al. Densely inte rconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011;144(2):296-309.
31. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132(4):631-644.
32. Narsinh KH, et al. Single cel l transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest. 2011;121(3):1217-1221.
33. Pina C, et al. Inferring rules of lineage commitment in haematopoiesis. Nat Cell Biol. 2012;14(3):287-294.
34. Stachura DL,Chou ST,Weiss MJ Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1 Blood. 2006, 107, 1, 87-97.
35. Campbell AE, Wilkinson-White L, Mackay JP, Matthews JM, Blobel GA. Analysis of disease-causing GATA1 mutations in murine gene complementation systems. Blood. 2013;121(26):5218-5227.
36. Chlon TM, Dore LC, Crispino JD. Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression. Mol Cell. 2012;47(4):608-621.
37. Letting DL, Chen YY, Rakowski C, Reedy S, Blobel GA. Context-dependent regulation of GATA-1 by friend of GATA-1. Proc Natl Acad Sci U S A. 2004;101(2):476-481.
38. Pal S, et al. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc Natl Acad Sci U S A. 2004;101(4):980-985.
39. Stark R, Brown G. Diffbind: differential binding anal ysis of ChIP-seq peak data. Bioconductor Web site. http://bioconductor.org/packages/release/bioc/vignettes/DiffBind/inst/doc/DiffBind.pdf. Published November 27, 2014. Accessed January 7, 2015.
40. Ross-Innes CS, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481(7381):389-393.
41. McLean CY, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28(5):495-501.
42. Pimkin M, et al. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis. Genome Res. 2014;24(12): 1932-1944.
43. Kazuki Y, et al. Down syndrome-Associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies. Sci Rep. 2014;4:6136.
44. May G, et al. Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell. 2 013;13(6):754-768.
45. Heyworth C, Pearson S, May G, Enver T. Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J. 2002;21(1 4):3770-3781.
46. Rhodes J, et al. Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev Cell. 2005;8(1):97-108.
47. Mancini E, et al. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2012;31(2):351-365.
48. Arinobu Y, et al. Recipro cal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell. 2007;1(4):416-427.
49. Weiss MJ, Orkin SH. T ranscription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci U S A. 1995;92(21):9623-9627.
50. Klimchenko O, et al. A common bipoten t progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood. 2009;114(8):1506-1517.
51. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 2005;105(2):617-626.
52. Ko LJ, Engel JD. DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol. 1993;13(7):4011-4022.
53. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol. 1993;13(7):3999-4010.
54. Burdach J, et al. Regions outside the DNA-binding domain are critical for proper in vivo specificity of an archetypal zinc finger transcription facto r. Nucleic Acids Res. 2014;42(1):276-289.
55. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differ entiation. Blood. 2003;101(11):4333-4341.
56. Kadri Z, et al. Direct binding of pRb/E2F-2 to GATA-1 regulates maturation and terminal cell division during erythropoiesis. PLoS Biol. 2009;7(6):e1000123.
57. Goldfarb AN. Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem. 2009;107(3):377-382.
58. Walkley CR, Sankaran VG, Orkin SH. Rb and hematopoiesis: stem cells to anemia. Cell Div. 2008;3:13.
59. Van Hook JW, Gill P, Cyr D, Kapur RP. Diamond-Blackfan anemia as an unusual cause of nonimmune hydrops fetalis: a case report. J Reprod Med. 1995;40(12):850-854.
60. Dunbar AE 3rd, Moore SL, Hinson RM. Fetal Diamond-Blackfan anemia associated with hydrops fetalis. Am J Perinatol. 2003;20(7):391-394.
61. Chou ST, et al. Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood. 2008;112(12):4503-4506.
62. Tunstall-Pedoe O, et al. Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood. 2008;112(12):4507-4511.
63. Roy A, et al. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy Proc Natl Acad Sci U S A. 2012;109(43):17579-17584.
64. Maclean GA, et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A. 2012;109(43):17567-17572.
65. Klusmann JH, et al. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev. 2010;24(15):1659-1672.
66. Toki T, et al. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome. Blood. 2013;121(16):3181-3184.
67. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4):e15.
68. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363-2367.
69. Gentleman RC, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80.
70. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307-315.
71. Letting DL, Rakowski C, Weiss MJ, Blobel GA. Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1. Mol Cell Biol. 2003;23(4):1334-1340.
72. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
73. Benjamini Y, Hochberg Y. Controlling the false discovery rate-A practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57(1):289-300.